Patent classifications
C07F7/24
SYNCHRONIZED PIEZOELECTRIC AND LUMINESCENCE MATERIAL AND ELEMENT INCLUDING THE SAME
There is provided a method of preparing a synchronized piezoelectric and luminescence material. The method includes mixing a solution (a) including light-emitting particles or precursors thereof and a solution (b) including ligands having a piezoelectric property in a polar solvent; and optionally, mixing a solution (c) including ligands having a piezoelectric property in an antisolvent together with the solution (a) and the solution (b), if necessary.
SYNCHRONIZED PIEZOELECTRIC AND LUMINESCENCE MATERIAL AND ELEMENT INCLUDING THE SAME
There is provided a method of preparing a synchronized piezoelectric and luminescence material. The method includes mixing a solution (a) including light-emitting particles or precursors thereof and a solution (b) including ligands having a piezoelectric property in a polar solvent; and optionally, mixing a solution (c) including ligands having a piezoelectric property in an antisolvent together with the solution (a) and the solution (b), if necessary.
Methods for stabilizing perovskites
The present disclosure relates to a composition that includes a material of at least one of a perovskite structure, a perovskite-like structure, and/or a perovskitoid structure, where the material includes an isotope of an element, the isotope has more neutrons than protons, and the isotope is incorporated into the perovskite structure, the perovskite-like structure, and/or the perovskitoid structure. In some embodiments of the present disclosure, the isotope may make up between greater than 0% and 100% of the element.
Methods for stabilizing perovskites
The present disclosure relates to a composition that includes a material of at least one of a perovskite structure, a perovskite-like structure, and/or a perovskitoid structure, where the material includes an isotope of an element, the isotope has more neutrons than protons, and the isotope is incorporated into the perovskite structure, the perovskite-like structure, and/or the perovskitoid structure. In some embodiments of the present disclosure, the isotope may make up between greater than 0% and 100% of the element.
Perovskite light-emitting device
A light-emitting layer for a halide perovskite light-emitting device, a method for manufacturing the same and a perovskite light-emitting device using the same are disclosed. The light-emitting layer can be manufactured by forming a first nanoparticle thin film by coating, on a member, a solution comprising halide perovskite nanoparticles having a halide perovskite nanocrystalline structure. Thereby, a nanoparticle light emitter has therein a halide perovskite having a crystal structure in which FCC and BCC are combined; and can show high color purity. In addition, it is possible to improve the luminescence efficiency and luminance of a device by making perovskite as nanoparticles and then introducing the same into a light-emitting layer.
Perovskite light-emitting device
A light-emitting layer for a halide perovskite light-emitting device, a method for manufacturing the same and a perovskite light-emitting device using the same are disclosed. The light-emitting layer can be manufactured by forming a first nanoparticle thin film by coating, on a member, a solution comprising halide perovskite nanoparticles having a halide perovskite nanocrystalline structure. Thereby, a nanoparticle light emitter has therein a halide perovskite having a crystal structure in which FCC and BCC are combined; and can show high color purity. In addition, it is possible to improve the luminescence efficiency and luminance of a device by making perovskite as nanoparticles and then introducing the same into a light-emitting layer.
PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED HIGH-AFFINITY AGENTS FOR ENDORADIOTHERAPY OF PROSTATE CANCER
Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer are disclosed.
PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED HIGH-AFFINITY AGENTS FOR ENDORADIOTHERAPY OF PROSTATE CANCER
Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer are disclosed.
ORGANIC-INORGANIC PEROVSKITE, FILM, LIGHT-EMITTING FILM, DELAYED FLUORESCENCE-EMITTING FILM, LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING LIGHT-EMITTING ELEMENT
An organic-inorganic perovskite satisfying E.sub.T<E.sub.T1 and E.sub.S-E.sub.T≤0.1 eV has a high emission efficiency. E.sub.S represents the excited singlet energy level in emission of an inorganic component, E.sub.T represents the excited triplet energy level in emission of an inorganic component, E.sub.T1 represents the excited triplet energy level in emission of an organic component.
ORGANIC-INORGANIC PEROVSKITE, FILM, LIGHT-EMITTING FILM, DELAYED FLUORESCENCE-EMITTING FILM, LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING LIGHT-EMITTING ELEMENT
An organic-inorganic perovskite satisfying E.sub.T<E.sub.T1 and E.sub.S-E.sub.T≤0.1 eV has a high emission efficiency. E.sub.S represents the excited singlet energy level in emission of an inorganic component, E.sub.T represents the excited triplet energy level in emission of an inorganic component, E.sub.T1 represents the excited triplet energy level in emission of an organic component.